Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Therapy After Long Term Denosumab Treatment
NCT05091099Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2022
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alendronate in osteoporosis, sponsored by National Taiwan University Hospital. Started Jan 2022; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT05091099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05091099.